Annual Current Liabilities
$6.83 M
-$4.69 M-40.71%
01 June 2022
Summary:
Pluristem Therapeutics annual total current liabilities is currently $6.83 million, with the most recent change of -$4.69 million (-40.71%) on 01 June 2022. During the last 3 years, it has fallen by -$4.69 million (-40.71%).PSTI Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Current Liabilities
$5.02 M
-$1.81 M-26.52%
01 September 2022
Summary:
Pluristem Therapeutics quarterly total current liabilities is currently $5.02 million, with the most recent change of -$1.81 million (-26.52%) on 01 September 2022.PSTI Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PSTI Current Liabilities Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | - |
| 3 y3 years | -40.7% | -51.6% |
| 5 y5 years | -16.3% | -36.0% |
PSTI Current Liabilities High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | ||||
| 5 y | 5 years | ||||
| alltime | all time | -40.7% | -56.4% |
Pluristem Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2022 | - | $5.02 M(-26.5%) |
| June 2022 | $6.83 M(-40.7%) | $6.83 M(-12.7%) |
| Mar 2022 | - | $7.82 M(-18.5%) |
| Dec 2021 | - | $9.60 M(-7.4%) |
| Sept 2021 | - | $10.37 M(-10.0%) |
| June 2021 | $11.52 M(+44.2%) | $11.52 M(+16.1%) |
| Mar 2021 | - | $9.92 M(-0.8%) |
| Dec 2020 | - | $10.00 M(+19.8%) |
| Sept 2020 | - | $8.35 M(+4.5%) |
| June 2020 | $7.99 M(-2.1%) | $7.99 M(+10.9%) |
| Mar 2020 | - | $7.20 M(+3.0%) |
| Dec 2019 | - | $6.99 M(-10.9%) |
| Sept 2019 | - | $7.84 M(-3.9%) |
| June 2019 | $8.16 M(-4.6%) | $8.16 M(-1.1%) |
| Mar 2019 | - | $8.25 M(+14.0%) |
| Dec 2018 | - | $7.23 M(-2.2%) |
| Sept 2018 | - | $7.40 M(-13.5%) |
| June 2018 | $8.55 M(+57.9%) | $8.55 M(+9.5%) |
| Mar 2018 | - | $7.81 M(+34.7%) |
| Dec 2017 | - | $5.80 M(+21.5%) |
| Sept 2017 | - | $4.77 M(-11.9%) |
| June 2017 | $5.41 M(-6.3%) | $5.41 M(-11.7%) |
| Mar 2017 | - | $6.13 M(+14.0%) |
| Dec 2016 | - | $5.38 M(+0.1%) |
| Sept 2016 | - | $5.37 M(-6.9%) |
| June 2016 | $5.78 M(-6.6%) | $5.78 M(+20.1%) |
| Mar 2016 | - | $4.81 M(+4.2%) |
| Dec 2015 | - | $4.61 M(+8.7%) |
| Sept 2015 | - | $4.24 M(-31.4%) |
| June 2015 | $6.18 M(-16.4%) | $6.18 M(+23.3%) |
| Mar 2015 | - | $5.02 M(-3.0%) |
| Dec 2014 | - | $5.17 M(-13.6%) |
| Sept 2014 | - | $5.99 M(-19.1%) |
| June 2014 | $7.40 M(+24.9%) | $7.40 M(+14.8%) |
| Mar 2014 | - | $6.44 M(+15.5%) |
| Dec 2013 | - | $5.58 M(-2.7%) |
| Sept 2013 | - | $5.73 M(-3.2%) |
| June 2013 | $5.92 M(+7.2%) | $5.92 M(+2.7%) |
| Mar 2013 | - | $5.76 M(-5.9%) |
| Dec 2012 | - | $6.13 M(+17.1%) |
| Sept 2012 | - | $5.23 M(-5.3%) |
| Date | Annual | Quarterly |
|---|---|---|
| June 2012 | $5.52 M(+173.6%) | $5.52 M(+13.8%) |
| Mar 2012 | - | $4.85 M(-2.5%) |
| Dec 2011 | - | $4.98 M(-1.4%) |
| Sept 2011 | - | $5.04 M(+150.0%) |
| June 2011 | $2.02 M(+57.5%) | $2.02 M(+5.9%) |
| Mar 2011 | - | $1.91 M(+28.8%) |
| Dec 2010 | - | $1.48 M(+20.2%) |
| Sept 2010 | - | $1.23 M(-4.0%) |
| June 2010 | $1.28 M(+52.5%) | $1.28 M(+13.9%) |
| Mar 2010 | - | $1.13 M(+6.4%) |
| Dec 2009 | - | $1.06 M(+18.9%) |
| Sept 2009 | - | $889.00 K(+5.8%) |
| June 2009 | $840.00 K(-21.6%) | $840.00 K(+28.8%) |
| Mar 2009 | - | $652.00 K(-22.9%) |
| Dec 2008 | - | $846.00 K(-0.8%) |
| Sept 2008 | - | $853.00 K(-20.4%) |
| June 2008 | $1.07 M(+46.3%) | $1.07 M(+9.2%) |
| Mar 2008 | - | $982.00 K(+29.2%) |
| Dec 2007 | - | $760.00 K(-6.7%) |
| Sept 2007 | - | $815.00 K(+11.2%) |
| June 2007 | $732.90 K(-0.2%) | $732.90 K(-72.7%) |
| Mar 2007 | - | $2.69 M(+304.3%) |
| Dec 2006 | - | $664.30 K(+18.5%) |
| Sept 2006 | - | $560.70 K(-23.7%) |
| June 2006 | $734.40 K(+62.8%) | $734.40 K(+21.9%) |
| Mar 2006 | - | $602.30 K(+6.2%) |
| Dec 2005 | - | $567.00 K(+55.4%) |
| Sept 2005 | - | $364.90 K(-19.1%) |
| June 2005 | $451.00 K(+15.2%) | $451.00 K(+27.4%) |
| Mar 2005 | - | $353.90 K(-13.8%) |
| Dec 2004 | - | $410.40 K(+3.3%) |
| Sept 2004 | - | $397.10 K(+1.4%) |
| June 2004 | $391.60 K(+53.0%) | $391.60 K(-17.1%) |
| Mar 2004 | - | $472.50 K(+44.5%) |
| Dec 2003 | - | $327.10 K(+30.9%) |
| Sept 2003 | - | $249.90 K(-2.4%) |
| June 2003 | $256.00 K(+178.6%) | $256.00 K(+896.1%) |
| Mar 2003 | - | $25.70 K(+37.4%) |
| Dec 2002 | - | $18.70 K(-77.0%) |
| Sept 2002 | - | $81.40 K(-11.4%) |
| June 2002 | $91.90 K | $91.90 K |
FAQ
- What is Pluristem Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Pluristem Therapeutics?
- What is Pluristem Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Pluristem Therapeutics?
What is Pluristem Therapeutics annual total current liabilities?
The current annual current liabilities of PSTI is $6.83 M
What is the all time high annual current liabilities for Pluristem Therapeutics?
Pluristem Therapeutics all-time high annual total current liabilities is $11.52 M
What is Pluristem Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of PSTI is $5.02 M
What is the all time high quarterly current liabilities for Pluristem Therapeutics?
Pluristem Therapeutics all-time high quarterly total current liabilities is $11.52 M